Video

Latham in Focus: Healthcare and Life Sciences — Alternative Deal Structures

December 22, 2025

Why have private equity investors gravitated toward partnership-driven instruments?

In this edition of Latham in Focus, Hamburg partner Christoph Engeler explores whether partnership-based deals become the new norm for healthcare and life sciences transactions.

Endnotes

Christoph W.G. Engeler

Hamburg

christoph.engeler@lw.com +49.40.4140.3360

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.

Endnotes

Contacts

Christoph W.G. Engeler